RSS-Feed abonnieren

DOI: 10.1055/s-0042-1757285
The Outcome of Progressive Uterine Sarcoma with Potential Bone Involvement

Abstract
High-grade endometrial stromal sarcoma (HGESS) is a very rare kind of uterine tumor that accounts for less than 2% of all uterine cancers. The usual sites of metastasis are the abdomen and lung, while bone metastasis is very rare, with only a few cases reported till now. We present a case of HGESS with bone metastasis and review the literature.
Informed Consent
Consent to participant and consent for publication were obtained properly.
Ethical Approval
All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the Helsinki declaration as revised in 2013 and its later amendments or comparable ethical standards.
Author's Contributions
All authors have contributed in writing the manuscript and collecting the required materials.
Publikationsverlauf
Artikel online veröffentlicht:
28. Oktober 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Ali RH, Rouzbahman M. Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. J Clin Pathol 2015; 68 (05) 325-332
- 2 Prat J, Mbatani N. Uterine sarcomas. Int J Gynaecol Obstet 2015; 131 (Suppl. 04) S105-S110
- 3 Carcangiu ML, Kurman RJ, Carcangiu ML, Herrington CS. WHO Classification of Tumours of Female Reproductive Organs. Lyon, France: International Agency for Research on Cancer; 2014
- 4 Denschlag D, Thiel FC, Ackermann S. et al. Sarcoma of the uterus. Guideline of the DGGG (S2k-Level, AWMF registry No. 015/074, August 2015). [published correction appears in Geburtshilfe Frauenheilkd. 2015 Oct;75(10):e3] Geburtshilfe Frauenheilkd 2015; 75 (10) 1028-1042
- 5 Pautier P, Floquet A, Gladieff L. et al. A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group. Ann Oncol 2013; 24 (04) 1099-1104
- 6 Koh WJ, Greer BE, Abu-Rustum NR. et al; National Comprehensive Cancer Network. Uterine sarcoma, version 1.2016: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2015; 13 (11) 1321-1331
- 7 Li F, Liao Z, Zhang C. et al. Apatinib as targeted therapy for sarcoma. Oncotarget 2018; 9 (36) 24548-24560
- 8 Date I, Yagyu Y, Bukeo T. Endometrial stromal sarcoma metastatic to the skull–case report. Neurol Med Chir (Tokyo) 1986; 26 (07) 571-574
- 9 Huang MI, Debernardo RL, Rodgers M, Hart DJ. Endometrial stromal sarcoma metastasis to the lumbar spine and sphenoid bone. Rare Tumors 2011; 3 (03) e27